Laurus Labs invests Rs 45 crore in JV KRKA Pharma for new manufacturing unit
Laurus Labs, a top pharmaceutical company, will invest €5 million in its joint venture with KRKA Pharma to build a new manufacturing facility for finished products by December 2025. Despite this, the shareholding structure will not change. In the first quarter of the fiscal year, Laurus Labs saw a considerable rise in profits.